PALI Palisade Bio, Inc.

Leading BioSciences, Inc. develops therapeutics to improve human health through therapeutic protection of the gastrointestinal mucosal barrier. The company was founded in 2005 and is based in Carlsbad, California.

As of 12/03/2021     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  04/28/2021
Outstanding shares:  13,574,049
Average volume:  243,034
Market cap:   $28,234,022
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    696389105
ISIN:        US6963891055
Valuation   (See tab for details)
PE ratio:   -3.04
PB ratio:   6.11
PS ratio:   0.00
Return on equity:   -661.95%
Net income %:   -518,969.92%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy